Page last updated: 2024-11-04

sulfamethoxazole and Leishmaniasis, Cutaneous

sulfamethoxazole has been researched along with Leishmaniasis, Cutaneous in 1 studies

Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.

Leishmaniasis, Cutaneous: An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes.

Research Excerpts

ExcerptRelevanceReference
"Among the different modalities for treatment of cutaneous leishmaniasis, liquid nitrogen is considered an effective therapy with very mild side-effects."2.68A 2-year study of liquid nitrogen therapy in cutaneous leishmaniasis. ( Abuloham, O; al-Majali, O; Bhowmik, KR; Hebeheba, H; Muhsen, M; Routh, HB, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
al-Majali, O1
Routh, HB1
Abuloham, O1
Bhowmik, KR1
Muhsen, M1
Hebeheba, H1

Trials

1 trial available for sulfamethoxazole and Leishmaniasis, Cutaneous

ArticleYear
A 2-year study of liquid nitrogen therapy in cutaneous leishmaniasis.
    International journal of dermatology, 1997, Volume: 36, Issue:6

    Topics: Administration, Cutaneous; Adolescent; Adult; Anti-Infective Agents; Antimony; Cicatrix; Cryosurgery

1997